Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
Recruiting
Observational Study
Prostate Cancer
Head and Neck Cancer
NSCLC
SCLC
Esophageal Cancer
Bladder Cancer
Rectum Cancer
Cervix Cancer
Other Carcinoma
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 649 (estimated)
- Sponsor
- Charite University, Berlin, Germany · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study focuses on the scientific and clinical evaluation of online adaptive radiotherapy (ART) using the Varian/SHS ETHOS treatment system. In this study, radiation treatment plans are dynamically adjusted on a daily basis over several weeks of therapy to account for anatomical shifts in either the tumour or adjacent normal tissue - a capability that has been difficult to achieve due to technic…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients (\>18 years)
* All tumor entities with an indication for radiotherapy and/or chemoradiotherapy
* Signed informed consent
Exclusion Criteria:
* Pregnancy
* Patients who are not capable of giving consent
Contacts